サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1388051

細菌抗原市場、シェア、規模、動向、産業分析レポート：抗原タイプ別、診断技術別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年

Bacterial Antigens Market Share, Size, Trends, Industry Analysis Report, By Antigen Type ; By Diagnostic Techniques; By End User; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
細菌抗原市場、シェア、規模、動向、産業分析レポート：抗原タイプ別、診断技術別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年09月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの最新調査によると、世界の細菌抗原市場規模は2032年までに2,009万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界の感染症負担の絶え間ない増加、効果的な診断・治療ソリューションの広範な導入と必要性、予防接種の重要性に対する人々の意識の高まり、製剤に細菌抗原を必要とする新しいワクチン開拓数の増加は、市場の需要と成長を後押しする主要な顕著な要因です。

さらに、バイオ製造プロセスの継続的な改善により、細菌抗原のより効率的でコスト効率の高い生産が可能になる一方で、特に発展途上国におけるワクチンや診断ツールの入手しやすさが向上し、抗原の特徴や能力の革新に焦点を当てた研究開発活動への投資が増加していることも、近い将来の製品需要を促進する可能性が高いです。

例えば、エバクシオンは2023年5月、ウイルス、細菌、がんワクチンの免疫反応全体を高める新しいアジュバント技術を発表しました。この技術はまた、ウイルスと細菌の両方の抗原に対して中和抗体とT細胞応答を誘導します。

様々な目に見えない人口統計学的・疫学的動向により、特に新興経済圏ではヘルスケア支出が継続的に拡大しており、自由化された外国投資基準、医療機器公園と政策、専用バルクドラッグ設置のための優遇措置など、いくつかの政策要因によって大きく支えられているため、細菌抗原がヘルスケア環境で採用・使用される機会は世界的に有利になると思われます。

これに加えて、特に資源が限られた環境では、迅速かつ正確なポイントオブケア診断検査に対する需要が高まっており、病院や診断ラボを含む様々なヘルスケア環境での展開や使用が容易な細菌抗原ベースの検査開発の普及が進んでおり、市場で事業を展開する企業にとって大きな収益機会への道が開けています。

細菌抗原市場レポートハイライト

クロストリジウム・ディフィシル・トキソイドA（Clostridium difficile toxoid A）分野が最大シェアを占めたが、これは主にヘルスケア環境における細菌感染の増加によるものです。

世界的に免疫測定技術の進歩が進んでいることから、免疫測定分野が最大シェアを占める

学術・研究機関分野は、抗原のさまざまな側面を研究するために研究機関で細菌抗原のニーズが高まっていることから、最も速いペースで成長します。

北米地域が世界市場を席巻、これは政府の好意的なイニシアチブの急増と人々の意識の高まりによる。

主な市場プレイヤーは、Ross Southern Laboratories、Thermo Fisher Scientific、The Native Antigen Company、Enzo Life Sciences、Creative Diagnosticsなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の細菌抗原市場に関する洞察

  • 細菌抗原市場- エンドユーザーのスナップショット
  • 細菌抗原市場力学
    • 促進要因と機会
      • さまざまな種類の細菌抗原の使用が増加
      • ワクチン接種の重要性に対する意識の高まり
    • 抑制要因と課題
      • 細菌抗原の複雑さと多様性
  • PESTEL分析
  • 細菌抗原市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 抗原タイプ別：世界の細菌抗原市場

  • 主な調査結果
  • イントロダクション
  • クロストリジウム・ディフィシル・トキソイドA
  • クロストリジウム・ディフィシル・トキソイドB
  • クラミジア・トラコマチス
  • 天然リポテイコ酸
  • 膣トリコモナス
  • その他

第6章 診断技術別：世界の細菌抗原市場

  • 主な調査結果
  • イントロダクション
  • ELISA
  • 免疫測定法
  • SDSページ
  • 血球凝集
  • 凝集試験
  • その他の診断手法

第7章 エンドユーザー別：世界の細菌抗原市場

  • 主な調査結果
  • イントロダクション
  • 診断研究所およびセンター
  • 学術研究機関
  • 病院

第8章 地域別：世界の細菌抗原市場

  • 主な調査結果
  • イントロダクション
    • 細菌抗原市場評価、地域別、2019-2032年
  • 細菌抗原市場-北米
    • 北米：細菌抗原市場、抗原タイプ別、2019-2032年
    • 北米：細菌抗原市場、エンドユーザー別、2019-2032年
    • 北米：細菌抗原市場、診断技術別、2019-2032年
    • 細菌抗原市場-米国
    • 細菌抗原市場- カナダ
  • 細菌抗原市場- 欧州
    • 欧州：細菌抗原市場、抗原タイプ別、2019～2032年
    • 欧州：細菌抗原市場、エンドユーザー別、2019-2032
    • 欧州：細菌抗原市場、診断技術別、2019～2032年
    • 細菌抗原市場- 英国
    • 細菌抗原市場- フランス
    • 細菌抗原市場- ドイツ
    • 細菌抗原市場- イタリア
    • 細菌抗原市場- スペイン
    • 細菌抗原市場- オランダ
    • 細菌抗原市場- ロシア
  • 細菌抗原市場- アジア太平洋
    • アジア太平洋：細菌抗原市場、抗原タイプ別、2019～2032年
    • アジア太平洋：細菌抗原市場、エンドユーザー別、2019～2032年
    • アジア太平洋：細菌抗原市場、診断技術別、2019～2032年
    • 細菌抗原市場- 中国
    • 細菌抗原市場- インド
    • 細菌抗原市場- マレーシア
    • 細菌抗原市場- 日本
    • 細菌抗原市場- インドネシア
    • 細菌抗原市場- 韓国
  • 細菌抗原市場-中東およびアフリカ
    • 中東およびアフリカ：細菌抗原市場、抗原タイプ別、2019～2032年
    • 中東およびアフリカ：細菌抗原市場、エンドユーザー別、2019～2032年
    • 中東およびアフリカ：細菌抗原市場、診断技術別、2019～2032年
    • 細菌抗原市場- サウジアラビア
    • 細菌抗原市場- アラブ首長国連邦
    • 細菌抗原市場- イスラエル
    • 細菌抗原市場- 南アフリカ
  • 細菌抗原市場-ラテンアメリカ
    • ラテンアメリカ：細菌抗原市場、抗原タイプ別、2019-2032年
    • ラテンアメリカ：細菌抗原市場、エンドユーザー別、2019-2032
    • ラテンアメリカ：細菌抗原市場、診断技術別、2019-2032年
    • 細菌抗原市場- メキシコ
    • 細菌抗原市場- ブラジル
    • 細菌抗原市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Becton
  • Dickinson and Company
  • BioFire Diagnostics
  • Creative Diagnostics
  • Enzo Life Sciences Inc.
  • Jena Bioscience GmbH
  • LGC Bioresearch Technologies
  • Merck & Co. Inc.
  • QED Bioscience Inc.
  • Ross Southern Laboratories
  • Synthetic Genomics
  • The Native Antigen Company Ltd.
  • Thermo Fisher Scientific
  • ZeptoMetrix Corporation
図表

List of Tables

  • Table 1 Global Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 2 Global Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 3 Global Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 4 Bacterial Antigens Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 6 North America: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 7 North America: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 10 U.S.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 12 Canada: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 13 Canada: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 15 Europe: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 16 Europe: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 18 UK: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 19 UK: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 21 France: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 22 France: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 24 Germany: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 25 Germany: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 27 Italy: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 28 Italy: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 30 Spain: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 31 Spain: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 34 Netherlands: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 36 Russia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 37 Russia: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 42 China: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 43 China: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 45 India: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 46 India: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 49 Malaysia: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 51 Japan: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 52 Japan: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 55 Indonesia: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 58 South Korea: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 66 UAE: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 67 UAE: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 69 Israel: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 70 Israel: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 73 South Africa: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 76 Latin America: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 79 Mexico: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 82 Brazil: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • Table 85 Argentina: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Bacterial Antigens Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Diagnostic Techniques
  • Figure 7. Global Bacterial Antigens Market, by Diagnostic Techniques, 2022 & 2032 (USD Million)
  • Figure 8. Market by Antigen Type
  • Figure 9. Global Bacterial Antigens Market, by Antigen Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Bacterial Antigens Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Bacterial Antigens Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Bacterial Antigens Market
目次
Product Code: PM3747

The global bacterial antigens market size is expected to reach USD 20.09 million by 2032, according to a new study by Polaris market research. The report "Bacterial Antigens Market Share, Size, Trends, Industry Analysis Report, By Antigen Type (Clostridium Difficile Toxoid A, Clostridium Difficile B, Chlamydia Trachomatis, Native Lipoteichoic Acid, Trichomonas Vaginalis, and Others); By Diagnostic Techniques; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The constant increase in the burden of infectious diseases globally and widespread adoption and need for effective diagnostic and therapeutic solutions, along with the growing people awareness towards the importance of vaccinations and the rising number of new vaccine developments that require bacterial antigens for their formulations, are major prominent factors boosting the market demand and growth.

Furthermore, ongoing improvements in biomanufacturing processes could lead to more efficient and cost-effective production of bacterial antigens while enhancing the accessibility of vaccines and diagnostic tools, particularly in developing countries and growing investments in research development activities focused on innovating antigens features and capabilities, will likely to propel the product demand in the near future.

For instance, in May 2023, Evaxion unveiled a new adjuvant technology that boosts the overall immune response of viral, bacterial, and cancer vaccines. This technology also induces neutralizing antibodies and T-cell responses against both viral and bacterial antigens.

With the continuous expansion in healthcare expenditure, especially in emerging economies due to various invisible demographic and epidemiologic trends, that are significantly supported by several policy factors like liberalized foreign investment norms, medical devices parks and regulations, and incentives for setting up dedicated bulk-drug, there will be lucrative opportunities for bacterial antigens to be adopted and used in healthcare settings globally.

Besides this, there has been increasing demand for rapid and accurate point-of-care diagnostic tests, particularly in resource-limited settings, and greater prevalence for developing bacterial antigen-based tests that are easy to deploy and use in various healthcare settings, including hospitals and diagnostic laboratories, and have paved the way for significant revenue opportunities for companies operating in the market.

Bacterial Antigens Market Report Highlights

Clostridium difficile toxoid A segment accounted for largest share, mainly due to rising incidences of bacterial infections into the healthcare settings

Immunoassay segment held the maximum share, on account of increasing advancements in immunoassay technologies globally

Academic & research institutes segment will grow at fastest pace, because of the rising need for bacterial antigens in research institutes to study different aspects of antigens

North America region dominated the global market, owing to surge in the number of favorable government initiatives and higher awareness among people

The key market players include Ross Southern Laboratories, Thermo Fisher Scientific, The Native Antigen Company, Enzo Life Sciences, and Creative Diagnostics

Polaris market research has segmented the bacterial antigens market report based on antigen type, diagnostic techniques, end user, and region:

Bacterial Antigens, Antigen Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Clostridium Difficile Toxoid A
  • Clostridium Difficile B
  • Chlamydia Trachomatis
  • Native Lipoteichoic Acid
  • Trichomonas Vaginalis
  • Others

Bacterial Antigens, Diagnostic Techniques Outlook (Revenue - USD Million, 2019 - 2032)

  • ELISA
  • Immunoassay
  • SDS-PAGE
  • Hemagglutination
  • Agglutination Test
  • Others

Bacterial Antigens, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Diagnostic Laboratories and Centers
  • Academic Research Institutes
  • Hospital

Bacterial Antigens, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Bacterial Antigens Market Insights

  • 4.1. Bacterial Antigens Market - End User Snapshot
  • 4.2. Bacterial Antigens Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing use of different types of bacterial antigens
      • 4.2.1.2. Rising awareness regarding the importance of vaccinations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complexity and variability of bacterial antigens
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Bacterial Antigens Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Bacterial Antigens Market, by Antigen Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
  • 5.3. Clostridium Difficile Toxoid A
    • 5.3.1. Global Bacterial Antigens Market, by Clostridium Difficile Toxoid A, by Region, 2019-2032 (USD Million)
  • 5.4. Clostridium Difficile Toxoid B
    • 5.4.1. Global Bacterial Antigens Market, by Clostridium Difficile Toxoid B, by Region, 2019-2032 (USD Million)
  • 5.5. Chlamydia Trachomatis
    • 5.5.1. Global Bacterial Antigens Market, by Chlamydia Trachomatis, by Region, 2019-2032 (USD Million)
  • 5.6. Native Lipoteichoic Acid
    • 5.6.1. Global Bacterial Antigens Market, by Native Lipoteichoic Acid, by Region, 2019-2032 (USD Million)
  • 5.7. Trichomonas Vaginalis
    • 5.7.1. Global Bacterial Antigens Market, by Trichomonas Vaginalis, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Bacterial Antigens Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Bacterial Antigens Market, by Diagnostic Techniques

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • 6.3. ELISA
    • 6.3.1. Global Bacterial Antigens Market, by ELISA, by Region, 2019-2032 (USD Million)
  • 6.4. Immunoassay
    • 6.4.1. Global Bacterial Antigens Market, by Immunoassay, by Region, 2019-2032 (USD Million)
  • 6.5. SDS-PAGE
    • 6.5.1. Global Bacterial Antigens Market, by SDS-PAGE, by Region, 2019-2032 (USD Million)
  • 6.6. Hemagglutination
    • 6.6.1. Global Bacterial Antigens Market, by Hemagglutination, by Region, 2019-2032 (USD Million)
  • 6.7. Agglutination Test
    • 6.7.1. Global Bacterial Antigens Market, by Agglutination Test, by Region, 2019-2032 (USD Million)
  • 6.8. Other Diagnostic Techniques
    • 6.8.1. Global Bacterial Antigens Market, by Other Diagnostic Techniques, by Region, 2019-2032 (USD Million)

7. Global Bacterial Antigens Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
  • 7.3. Diagnostic Laboratories and Centers
    • 7.3.1. Global Bacterial Antigens Market, by Diagnostic Laboratories and Centers, By Region, 2019-2032 (USD Million)
  • 7.4. Academic and Research Institutes
    • 7.4.1. Global Bacterial Antigens Market, by Academic and Research Institutes, By Region, 2019-2032 (USD Million)
  • 7.5. Hospital
    • 7.5.1. Global Bacterial Antigens Market, by Hospital, By Region, 2019-2032 (USD Million)

8. Global Bacterial Antigens Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Bacterial Antigens Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Bacterial Antigens Market - North America
    • 8.3.1. North America: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.3.4. Bacterial Antigens Market - U.S.
      • 8.3.4.1. U.S.: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.3.5. Bacterial Antigens Market - Canada
      • 8.3.5.1. Canada: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • 8.4. Bacterial Antigens Market - Europe
    • 8.4.1. Europe: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.4. Bacterial Antigens Market - UK
      • 8.4.4.1. UK: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.5. Bacterial Antigens Market - France
      • 8.4.5.1. France: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.6. Bacterial Antigens Market - Germany
      • 8.4.6.1. Germany: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.7. Bacterial Antigens Market - Italy
      • 8.4.7.1. Italy: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.8. Bacterial Antigens Market - Spain
      • 8.4.8.1. Spain: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.9. Bacterial Antigens Market - Netherlands
      • 8.4.9.1. Netherlands: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.4.10. Bacterial Antigens Market - Russia
      • 8.4.10.1. Russia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • 8.5. Bacterial Antigens Market - Asia Pacific
    • 8.5.1. Asia Pacific: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.5.4. Bacterial Antigens Market - China
      • 8.5.4.1. China: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.5.5. Bacterial Antigens Market - India
      • 8.5.5.1. India: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.5.6. Bacterial Antigens Market - Malaysia
      • 8.5.6.1. Malaysia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.5.7. Bacterial Antigens Market - Japan
      • 8.5.7.1. Japan: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.5.8. Bacterial Antigens Market - Indonesia
      • 8.5.8.1. Indonesia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.5.9. Bacterial Antigens Market - South Korea
      • 8.5.9.1. South Korea: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • 8.6. Bacterial Antigens Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.6.4. Bacterial Antigens Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.6.5. Bacterial Antigens Market - UAE
      • 8.6.5.1. UAE: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.6.6. Bacterial Antigens Market - Israel
      • 8.6.6.1. Israel: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.6.7. Bacterial Antigens Market - South Africa
      • 8.6.7.1. South Africa: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
  • 8.7. Bacterial Antigens Market - Latin America
    • 8.7.1. Latin America: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.7.4. Bacterial Antigens Market - Mexico
      • 8.7.4.1. Mexico: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.7.5. Bacterial Antigens Market - Brazil
      • 8.7.5.1. Brazil: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
    • 8.7.6. Bacterial Antigens Market - Argentina
      • 8.7.6.1. Argentina: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Becton
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BioFire Diagnostics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Creative Diagnostics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Enzo Life Sciences Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Jena Bioscience GmbH
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. LGC Bioresearch Technologies
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck & Co. Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. QED Bioscience Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Ross Southern Laboratories
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Synthetic Genomics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. The Native Antigen Company Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Thermo Fisher Scientific
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. ZeptoMetrix Corporation
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development